How much is Theranos worth in 2026?

Theranos has a current valuation of N/A based on their Unknown round and secondary market data.

How much funding has Theranos raised?

Theranos has raised N/A in total funding across 1 funding rounds.

Theranos

Theranos valuation and funding history | 1 funding rounds

Current Valuation

N/A

Total Funding Raised

N/A

Across 1 round

Last Round

Unknown

Amount undisclosed

Last Funding

Unknown

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
N/A	Unknown	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Theranos is currently valued at N/A.

Track Theranos Valuation Updates

Get notified when Theranos raises new funding or valuation changes

Explore More Data

Detailed analysis for Theranos

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Theranos's valuation history, funding rounds, and growth metrics.

No credit card required

What is Theranos Worth in 2026?

Theranos is a leading private company in the technology sector. Track Theranos's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Theranos Valuation is Determined

Private company valuations like Theranos's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.